Parnassus Investments
Parnassus Endeavor Fund
Parnassus Endeavor Fund Portfolio 13F
Parnassus Endeavor Fund Holdings Activity
- Portfolio value:
- $4.54B≈ (+$56M≈)
- Previous value:
- $4.48B≈
- # of changes:
- 52
- New positions:
- 6
- Reported for:
- 30 Jun 2025 (Q2)
- Latest filing date:
- 29 Jul 2025
Parnassus Endeavor Fund has disclosed a total of 52 changes to the portfolio in the (2025 Q2) SEC report(s): increased the number of shares of 16, bought 6 totally new, decreased the number of shares of 23 and completely sold out 7 position(s).
What stocks did Parnassus Endeavor Fund buy in 2025 Q2?
During 2025 Q2 Parnassus Endeavor Fund has bought 22 securities out of which top 5 purchases (by % change to portfolio) were (JPM) JPMorgan Chase & Co (added shares +38.58%), (GOOGL) Alphabet Inc, CL-A (added shares +24.75%), (ORCL) Oracle Corp (added shares +1.62%), (DHI) DR Horton Inc (added shares +2.58%) and (AMZN) Amazon.com Inc (added shares +3.46%).
In the 2025 Q2 report(s) the following changes have been made to the top investments: (DE) Deere & Company (reduced shares -4.21%), (SPGI) S&P Global Inc (reduced shares -5.94%), (BAC) Bank of America Corp (reduced shares -10.69%), (CBRE) CBRE Group Inc, CL-A (reduced shares -0.57%) and (JPM) JPMorgan Chase & Co (added shares +38.58%).
52 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Thermo Fisher Scientific Inc
|
new
|
+192,274
|
192,274
|
+1.72%
|
$405.46
|
+41.24%($572.69)
|
1.72%
|
2025 Q2
|
≈ 0.25 years
|
|
|
|
Regeneron Pharmaceuticals Inc
|
new
|
+101,084
|
101,084
|
+1.17%
|
$525.00
|
+44.51%($758.68)
|
1.17%
|
2025 Q2
|
≈ 0.25 years
|
|
|
|
Walmart Inc
|
new
|
+466,056
|
466,056
|
+1%
|
$97.78
|
+13.73%($111.21)
|
1.00%
|
2025 Q2
|
≈ 0.25 years
|
|
|
|
Linde plc Ordinary Shares
|
new
|
+172,806
|
172,806
|
+1.79%
|
$469.18
|
+1.59%($476.65)
|
1.79%
|
2025 Q2
|
≈ 0.25 years
|
|
|
|
Danaher Corp
|
new
|
+392,218
|
392,218
|
+1.71%
|
$197.54
|
-0.75%($196.06)
|
1.71%
|
2025 Q2
|
≈ 0.25 years
|
|
|
|
Willis Towers Watson PLC
|
new
|
+340,315
|
340,315
|
+2.3%
|
$306.50
|
+8.87%($333.68)
|
2.30%
|
2025 Q2
|
≈ 0.25 years
|
|
|
|
JPMorgan Chase & Co
|
+38.58%
|
+144,227
|
518,049
|
+0.92%
|
$289.91
|
+21.99%($353.66)
|
3.31%
|
2025 Q1
|
≈ 0.50 years
|
|
|
|
Alphabet Inc, CL-A
|
+24.75%
|
+138,991
|
700,500
|
+0.54%
|
$176.23
|
+100.73%($353.76)
|
2.72%
|
2021 Q4
|
≈ 3.75 years
|
|
|
|
Brookfield Renewable Corp
|
+13.56%
|
+361,652
|
3,029,290
|
+0.26%
|
$32.78
|
+2.09%($33.47)
|
2.19%
|
2023 Q3
|
≈ 2.00 years
|
|
|
|
Novo Nordisk A/S
|
+9.23%
|
+85,463
|
1,011,546
|
+0.13%
|
$69.02
|
-31.82%($47.06)
|
1.54%
|
2024 Q4
|
≈ 0.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.